News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
566,428 Results
Type
Article (45703)
Company Profile (120)
Press Release (520605)
Multimedia
Podcasts (82)
Webinars (12)
Section
Business (155614)
Career Advice (2412)
Deals (29063)
Drug Delivery (120)
Drug Development (71306)
Employer Resources (151)
FDA (15845)
Job Trends (12487)
News (279183)
Policy (30562)
Tag
Academia (2370)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (82)
Alliances (37095)
ALS (89)
Alzheimer's disease (1454)
Antibody-drug conjugate (ADC) (138)
Approvals (15801)
Artificial intelligence (245)
Autoimmune disease (27)
Automation (12)
Bankruptcy (318)
Best Places to Work (9674)
BIOSECURE Act (22)
Biosimilars (114)
Biotechnology (72)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (268)
Cancer (2174)
Cardiovascular disease (189)
Career advice (2016)
Career pathing (33)
CAR-T (144)
Cell therapy (419)
Cervical cancer (20)
Clinical research (57986)
Collaboration (731)
Compensation (525)
Complete response letters (29)
COVID-19 (2643)
CRISPR (43)
C-suite (224)
Cystic fibrosis (97)
Data (2067)
Decentralized trials (2)
Denatured (14)
Depression (52)
Diabetes (272)
Diagnostics (5488)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (42)
Drug discovery (104)
Drug pricing (122)
Drug shortages (30)
Duchenne muscular dystrophy (97)
Earnings (66422)
Editorial (44)
Employer branding (20)
Employer resources (136)
Events (91833)
Executive appointments (661)
FDA (17073)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (655)
Gene editing (105)
Generative AI (22)
Gene therapy (320)
GLP-1 (799)
Government (4147)
Grass and pollen (6)
Guidances (56)
Healthcare (15619)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (141)
Indications (26)
Infectious disease (2789)
Inflammatory bowel disease (133)
Inflation Reduction Act (9)
Influenza (49)
Intellectual property (89)
Interviews (450)
IPO (14573)
IRA (48)
Job creations (3202)
Job search strategy (1673)
Kidney cancer (11)
Labor market (32)
Layoffs (512)
Leadership (23)
Legal (7187)
Liver cancer (73)
Lung cancer (310)
Lymphoma (148)
Machine learning (7)
Management (51)
Manufacturing (296)
MASH (70)
Medical device (11601)
Medtech (11604)
Mergers & acquisitions (15003)
Metabolic disorders (734)
Multiple sclerosis (79)
NASH (22)
Neurodegenerative disease (101)
Neuropsychiatric disorders (33)
Neuroscience (1998)
NextGen: Class of 2025 (5213)
Non-profit (3377)
Now hiring (18)
Obesity (405)
Opinion (224)
Ovarian cancer (69)
Pain (87)
Pancreatic cancer (78)
Parkinson's disease (150)
Partnered (16)
Patents (231)
Patient recruitment (100)
Peanut (45)
People (44282)
Pharmaceutical (35)
Pharmacy benefit managers (21)
Phase I (17210)
Phase II (25204)
Phase III (20525)
Pipeline (1178)
Policy (166)
Postmarket research (2377)
Preclinical (7138)
Press Release (39)
Prostate cancer (110)
Psychedelics (36)
Radiopharmaceuticals (222)
Rare diseases (399)
Real estate (4426)
Recruiting (60)
Regulatory (21404)
Reports (32)
Research institute (2102)
Resumes & cover letters (402)
Rett syndrome (4)
RNA editing (3)
RSV (47)
Schizophrenia (76)
Series A (122)
Series B (80)
Service/supplier (10)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (132)
Sponsored (33)
Startups (2831)
State (1)
Stomach cancer (16)
Supply chain (72)
Tariffs (45)
The Weekly (67)
Vaccines (768)
Venture capitalists (43)
Weight loss (295)
Women's health (31)
Worklife (20)
Date
Today (168)
Last 7 days (844)
Last 30 days (2523)
Last 365 days (30586)
2025 (10179)
2024 (32378)
2023 (36371)
2022 (46535)
2021 (50225)
2020 (47213)
2019 (38181)
2018 (28900)
2017 (28837)
2016 (27379)
2015 (30649)
2014 (24140)
2013 (19589)
2012 (21049)
2011 (21524)
2010 (19477)
Location
Africa (683)
Alabama (47)
Alaska (6)
Arizona (179)
Arkansas (10)
Asia (32449)
Australia (5675)
California (5685)
Canada (1610)
China (431)
Colorado (242)
Connecticut (270)
Delaware (133)
Europe (78722)
Florida (848)
Georgia (188)
Hawaii (1)
Idaho (39)
Illinois (460)
India (24)
Indiana (260)
Iowa (11)
Japan (149)
Kansas (85)
Kentucky (13)
Louisiana (7)
Maine (62)
Maryland (850)
Massachusetts (4285)
Michigan (188)
Minnesota (344)
Mississippi (1)
Missouri (73)
Montana (12)
Nebraska (19)
Nevada (57)
New Hampshire (53)
New Jersey (1618)
New Mexico (15)
New York (1595)
North Carolina (919)
North Dakota (6)
Northern California (2518)
Ohio (162)
Oklahoma (8)
Oregon (28)
Pennsylvania (1240)
Puerto Rico (10)
Rhode Island (21)
South America (1054)
South Carolina (20)
South Dakota (1)
Southern California (2141)
Tennessee (87)
Texas (797)
United States (21194)
Utah (160)
Virginia (134)
Washington D.C. (60)
Washington State (515)
West Virginia (3)
Wisconsin (54)
566,428 Results for "sifi societa industria farmaceutica italiana s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
January 22, 2025
·
4 min read
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
Press Releases
SIFI announces collaboration with the University of California, San Francisco on Acanthamoeba Keratitis
March 19, 2025
·
5 min read
Drug Development
SIFI (Societa Industria Farmaceutica Italiana) Announces the Publication of its Phase I Study on Polihexanide in the British Journal of Ophthalmology
SIFI, a leading ophthalmic company, announced today the publication of clinical results from its Phase I trial of polihexanide in healthy volunteers.
February 1, 2021
·
3 min read
Press Releases
SIFI provides updates on the UK and US regulatory pathways for AKANTIOR® in the treatment of acanthamoeba keratitis
December 16, 2024
·
3 min read
Fabbrica Italiana Sintetici (F.I.S.) Selects Kinaxis for Supply Chain Planning
Kinaxis® Inc., the leading supply chain management platform, was selected by F.I.S. - Fabbrica Italiana Sintetici S.p.A. to enable concurrent planning in its supply chain.
August 22, 2023
·
2 min read
Press Releases
SIFI Receives European Commission Approval for AKANTIOR®
August 26, 2024
·
4 min read
Business
SIFI Announces License Agreement With Avanzanite Bioscience for Akantior®
SIFI announced that it has partnered with Avanzanite Bioscience, a Dutch specialty pharmaceutical company, to exclusively commercialize and distribute AKANTIOR® in 26 Countries within the European Economic Area and Switzerland.
January 10, 2023
·
5 min read
Press Releases
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors
April 21, 2025
·
4 min read
Press Releases
David P. King Joins Truvian’s Advisory Board
January 13, 2025
·
2 min read
1 of 56,643
Next
